Open AccessFacial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
Author(s) -
Yaping Li,
Ying Yang,
MuQi Wang,
Xin Zhang,
Wenjun Wang,
Mei Li,
Fengping Wu,
Shuangsuo Dang
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i15.3372
Subject(s) - medicine , edema , tamsulosin , drug , spironolactone , muscle hypertrophy , ombitasvir , methadone , hepatitis c virus , gastroenterology , ribavirin , anesthesia , pharmacology , hyperplasia , virus , immunology , heart failure
New direct-acting antivirals (DAAs)-based anti-hepatitis C virus (HCV) therapies are highly effective in patients with HCV infection. However, safety data are lacking regarding HCV treatment with DAAs and drugs for comorbidities.